Not all people with CLL demand therapy. Regardless of all recent improvements, the iwCLL nevertheless suggests watchful observation for patients with asymptomatic illness.86 This suggestion is predicated on no less than two randomized trials evaluating observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR). 学習資料をアップロードして、すべ... https://bobw853qxe0.bloggerbags.com/profile